Creating a Robust Antimicrobial Stewardship Program
June 2012 - Vol. 9 No. 6 - Page #36

The incidence of antimicrobial resistance has risen dramatically, becoming a major public health concern over the past several years. Health care providers and patients are faced with infections caused by multidrug-resistant organisms for which few, if any, treatment options remain. The principal driver of this resistance is the use of antimicrobial agents. Not only does inappropriate antimicrobial use lead to the development of drug resistance, but also antimicrobials as a class are among the drugs commonly associated with drug toxicity and adverse effects, including collateral damage such as Clostridium difficile disease. Importantly, as much as 50% of antimicrobial use in the inpatient setting is either unnecessary or suboptimal.1 For example, up to 80% of acute bronchitis patients are prescribed antibiotics, despite the fact that acute bronchitis is primarily the result of viruses.2 Curbing the widespread misuse of antimicrobials through antimicrobial stewardship presents an opportunity to improve patient outcomes and decrease resistance. 

To read the full article, please log in or register.

Current Issue

Our mission is to provide health system professionals with information to streamline operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field.